PDGFRA and neoplasm: Both TAS-115 and pazopanib blocked the phosphorylation of PDGFRα at Tyr754, Tyr762, Tyr849, Tyr1018, as well as the phosphorylation of downstream effectors in SYO-1 xenograft tumours (Fig. 5b).